Preliminary study about the possible glycemic clinical advantage in using a fixed combination of Berberis aristata and Silybum marianum standardized extracts versus only Berberis aristata in patients with type 2 diabetes
Francesco Di Pierro(University of Insubria), Nicola Villanova(IRCCS Azienda Ospedliero-Universitaria di Bologna Policlinico di Sant'Orsola), Pietro Putignano(Azienda Ospedaliera San Gerardo), Simona Moscatiello(IRCCS Azienda Ospedliero-Universitaria di Bologna Policlinico di Sant'Orsola), Luca Montesi(IRCCS Azienda Ospedliero-Universitaria di Bologna Policlinico di Sant'Orsola)
Cited by 78
Related Papers
The Battle of the Water Sensor Networks (BWSN): A Design Challenge for Engineers and Algorithms
|Journal of Water Resources Planning and Management|2008|583
A role for quercetin in coronavirus disease 2019 (COVID‐19)
|Phytotherapy Research|2020|299
An Investigation on Preference Order Ranking Scheme for Multiobjective Evolutionary Optimization
|IEEE Transactions on Evolutionary Computation|2007|283
Possible Therapeutic Effects of Adjuvant Quercetin Supplementation Against Early-Stage COVID-19 Infection: A Prospective, Randomized, Controlled, and Open-Label Study
|International Journal of General Medicine|2021|183